23/04/2014 06:58:17 Free Membership Login

Bioseek Company Financial Information

 Company name: Bioseek
 EPIC: ATD (delisted) Trading Currency: GBX
 Market Sector: SQQ3 ISIN: GB0009231639
 Market Segment: SSQ3 Share Type: DE
 WWW Address: http://www.bioseekinc.com/ Description: ORD 5P
 Price Price Change [%] Bid Ask Open High Low Volume
 0.50 mages.advfn.com/imagesnew/2/us/dot 0.0 [0.00] - - - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 0.59 118.48 1.03 -4.16 - - - -

Bioseek Key Figures

(at previous day's close)
Market Cap.0.59m
Shares In Issue118.48m
Prev. Close0.50
PE Ratio- 
Dividend Yield-%
EPS - basic-4.16p
Dividend PS-p
Dividend Cover- 
Cash Flow PS0.42p
Return On Equity (ROE)-114.06%
Operating Margin-27.40%
PEG Factor- 
EPS Growth Rate-%
Dividends PS Growth Rate-%
Net Debt10.41m
Gross Gearing72.64%
Quick Assets8.72m
Net Working Capital1.87m
Intangibles / Fixed Assets52.76%
Turnover PS13.08p
Pre-Tax Profit PS-3.58p
Retained Profit PS-4.47p
Cash PS1.62p
Net Cash PS-7.72p
Net Tangible Asset Value PS *2.12p
Net Asset Value PS3.92p
Spread- (-%) 

Bioseek Balance Sheet


Bioseek Share Price

Sorry No Data Available

Bioseek Share Price (5 years)

Bioseek Historic Returns

Sorry No Data Available

Bioseek Key Management Ratios

Bioseek Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio1.66 
PE Ratio- 
Tobin's Q Ratio 0.02 
Tobin's Q Ratio (excl. intangibles)0.02 
Dividend Yield-%
Market-to-Book Ratio0.13 
Price-to-Pre-Tax Profit PS-0.14 
Price-to-Retained Profit PS-0.11 
Price-to-Cash Flow PS1.18 
Price-to-Sales PS0.04 
Price-to-Net Tangible Asset Value PS0.24 
Price-to-Cash PS0.31 
Net Working Capital PS1.58 
Price Pct to Working Capital PS0.32%
Earnings Yield-%
Average PE3.90 
Years in average1 
PE to PE average-%

Bioseek Financial Ratios

(Leverage Ratios)
Debt Ratio21.34%
Debt-to-Equity Ratio0.27 
Debt-to-Equity Ratio (excl. Intgbl)0.50 
Debt-to-Equity Market Value2.13 
Net Gearing61.35%
Net Gearing (excl. Intangibles)70.14%
Gross Gearing72.64%
Gross Gearing (excl. Intangibles)83.05%
Gearing Under 1 Year65.22%
Gearing Under 1 Year (excl. Intgbl)74.57%
(Liquidity Ratios)
Net Working Capital to Total Assets11.02%
Current Ratio1.17 
Quick Ratio (Acid Test)0.79 
Liquidity Ratio0.17 
Cash & Equiv/Current Assets14.81%
(Solvency Ratios)
Enterprise Value-0.06m
CFO/Attributable Profit- 
Total Debt/Equity Market Value20.80 
Total Debt/Sales0.80 
Total Debt/Pre-Tax Profit-2.90 
Total Debt12.32m
Total Debt/Net Current Assets6.59%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-8.05%
Earn drops > 5% in 10yrs5 
Beta (60-Mnth)Beta (36-Mnth)
Alpha (60-Mnth)Alpha (36-Mnth)

Bioseek Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-71.98%
Return On Assets (ROA)-17.43%
Net Profit Margin-34.15%
Assets Turnover0.51 
Return On Equity (ROE)-114.06%
Return On Investment (ROI)-36.31%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-34.15%
(Asset Utilisation Multiples)
Shareholders Equity Turnover1.39 
Fixed Assets Turnover1.61 
Current Assets Turnover0.75 
Net Working Capital Turnover 
Inventory Turnover1.98 
(Other Operating Ratios)
Total Assets-to-Sales1.96 
Debt Collection Period198.88Days

Bioseek Dividends

Sorry No Data Available

Bioseek Fundamentals

 31 Dec 2008 (GBP)31 Dec 2009 (GBP)31 Dec 2010 (USD)31 Dec 2011 (USD)
pre tax profit3.9826.18%-1.28-10.69%-2.04-9.58%-6.60-27.40%m
attributable profit3.8825.47%-1.08-9.03%-2.07-9.73%-8.23-34.15%m
retained profit3.8825.47%-1.08-9.03%-2.07-9.73%-8.23-34.15%m
eps - basic3.53 -0.96 -1.80 -7.00 
eps - diluted3.53 -0.96 -1.80 -7.00 
dividends per share- - - - 

Bioseek Balance Sheet

 31 Dec 2008 (GBP)31 Dec 2009 (GBP)31 Dec 2010 (USD)31 Dec 2011 (USD)
 31 Dec 2008 (GBP)31 Dec 2009 (GBP)31 Dec 2010 (USD)31 Dec 2011 (USD)
fixed assets fixed assets0.462.79%0.483.39%3.399.85%2.9611.22%m
intangibles intangibles0.694.15%0.825.88%4.7813.90%3.3112.53%m
fixed investments fixed investments--%0.715.06%4.8414.09%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks4.4626.86%5.5439.54%9.1426.58%6.5524.83%m
debtors debtors4.1124.76%2.2916.34%6.3118.36%10.5840.12%m
cash & securities cash & securities6.8841.44%4.1729.79%5.9217.22%2.9811.29%m
creditors - short creditors - short4.2725.73%3.3523.93%14.3941.86%17.2065.22%m
creditors - long creditors - long--%0.231.64%4.8314.04%1.967.42%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves12.3374.27%10.4374.44%15.1644.10%7.2127.36%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Bioseek Cash Flow Statement

31 Dec 2008 (GBP)31 Dec 2009 (GBP)31 Dec 2010 (USD)31 Dec 2011 (USD)
Operating CF4.33-2.40-4.890.78m
Pre-Financing CF4.20-2.77-3.690.29m
Retained CF4.60-2.75-0.73-2.94m

Bioseek Brokers

Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Piper Jaffray LtdMarket Maker(MMF)Broker/DealerPIPRPIPRGB21
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us lse atd140423 06:58